Recommended Injection Sites Cagrilintide is administered via subcutaneous injection in three primary sites: Abdomen The most common injection site, offering consistent absorption
Glucagon-like peptide-1 ( GLP-1 ) receptor agonists, such as semaglutide (Wegovy) or tirzepatide (Zepbound), reduce hunger and cravings, making it easier to maintain a calorie deficit during plateaus
Desipramine induces eryptosis in human erythrocytes, an effect blunted by nitric oxide donor sodium nitroprusside and N-acetyl-L-cysteine but enhanced by Calcium depletion
While effective, it can cause mild side effects such as redness, swelling, tenderness, and bruising
Common side effects include nausea, vomiting, diarrhea, constipation and abdominal pain, as well as headache and dizziness